Clinical Trials List
Protocol NumberM24-305
2024-03-01 - 2026-03-31
Phase III
Not yet recruiting1
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2024/02/21
Investigators and Locations
Co-Principal Investigator
- YEN-FENG WANG 無
- 陳世彬 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
1300 participants
